Ajou University repository

Cancer Communications
ISSN
  • 2523-3548
Publisher

Wiley

Listed on
(Coverage)

JCR2018-2023

SJR2018-2020;2022-2023

CiteScore2017-2023

SCIE2018-2024

SCOPUS2018-2024

MEDLINE2018-2024

DOAJ2019-2024

EMBASE2018-2024

OA Info.
OA oa mark

based on the information

  • 2019;2020;2021;2022;2023;2024;2025;
Keywords clinical trials, epidemiology, cellular biology, cancer, molecular biology, genetics
Review Process Anonymous peer review
Journal info.
pages
Licences CC BY, CC BY-NC-ND
Copyrights No
DOAJ Coverage Added on Date : 2018-11-06T15:57:39Z
Subject(s) Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Active
Active

based on the information

  • SCOPUS:2024-10
Country
USA
Aime & Scopes
Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.
Article List

Showing results 1 to 2 of 2

Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinomaoa mark
  • Hyun, Sangyeop;
  • Han, Youngmin;
  • Moon, Jae Yun;
  • Suh, Young Ah;
  • Yun, Won Gun;
  • Kwon, Wooil;
  • Lee, Jong Eun;
  • Kim, Daeun;
  • Ku, Ja Lok;
  • Jang, Jin Young;
et al
  • 2024-08-01
  • Cancer Communications, Vol.44, pp.921-925
  • John Wiley and Sons Inc
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapyoa mark
  • Jung, Keunok;
  • Ko, Deok Han;
  • Jang, Jeong Yun;
  • Kim, Young Rong;
  • Heo, Jung Yeon;
  • Kim, Yong Sung
  • 2024-01-01
  • Cancer Communications, Vol.44, pp.173-177
  • John Wiley and Sons Inc
1